Register entry

Lonza Biologics Tuas Pte. Ltd.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Labeller names
4
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 11.

Dosage formNDCs
liquid11
RouteNDCs
Labeller name on the listingNDCs
lonza biologics tuas pte ltd.5
lonza biologics tuas pte. ltd.4
lonza biologics tuas pte. ltd.1
lonza biologics tuas pte.ltd.1
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
-Adalimumabliquid69438-0009DRUG FOR FURTHER PROCESSING
-Adalimumab, Citrate Freeliquid69438-0010DRUG FOR FURTHER PROCESSING
-EFGARTIGIMOD ALFAliquid69438-0011DRUG FOR FURTHER PROCESSING
-Eculizumabliquid69438-0001DRUG FOR FURTHER PROCESSING
-Lebrikizumabliquid69438-0014DRUG FOR FURTHER PROCESSING
-Trastuzumabliquid69438-0008DRUG FOR FURTHER PROCESSING
-dornase alfaliquid69438-0012DRUG FOR FURTHER PROCESSING
-efgartigimod SCliquid69438-0013DRUG FOR FURTHER PROCESSING
-infliximabliquid69438-0005DRUG FOR FURTHER PROCESSING
-luspaterceptliquid69438-0006DRUG FOR FURTHER PROCESSING
-narsoplimabliquid69438-0015DRUG FOR FURTHER PROCESSING
Compare

Other companies listing adalimumab

Enquiry

Common questions

Is Lonza Biologics Tuas Pte. Ltd. FDA approved?
Lonza Biologics Tuas Pte. Ltd. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Lonza Biologics Tuas Pte. Ltd. make?
11 products are listed under Lonza Biologics Tuas Pte. Ltd. in the openFDA NDC Directory, most often as liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.